Dp. Wade et al., CHARACTERIZATION OF MULTIPLE ENHANCER REGIONS UPSTREAM OF THE APOLIPOPROTEIN(A) GENE, The Journal of biological chemistry, 272(48), 1997, pp. 30387-30399
Plasma concentrations of the atherogenic lipoprotein(a) (Lp(a)) are pr
edominantly determined by inherited sequences within or closely linked
to the apolipoprotein(a) gene locus, Much of the interindividual vari
ability in Lp(a) levels is likely to originate at the level of apo(a)
gene transcription, However, the liver-specific apo(a) basal promoter
is extremely weak and does not exhibit common functional variations th
at affect plasma Lp(a) concentrations, In a search for additional apo(
a) gene control elements, we have identified two fragments with enhanc
er activity within the 40-kilobase pair apo(a)-plasminogen intergenic
region that coincide with DNase I-hypersensitive sites (DHII and DHIII
) observed in liver chromatin of mice expressing a human apo(a) transg
ene. Neither enhancer exhibits tis sue specificity. DHIII activity was
mapped to a BOG-base pair fragment containing nine DNase I-protected
elements (footprints) that stimulates luciferase expression from the a
po(a) promoter 10-15-fold in HepG2 cells, Binding of the ubiquitous tr
anscription factor Spl plays a major role in the function of this enha
ncer, but no single site was indispensable for activity, DHIII com pri
ses part of the regulatory region of an inactive long interspersed nuc
leotide element 1 retrotransposon, raising the possibility that retrot
ransposon insertion can influence the regulation of adjacent genes. DH
II enhancer activity was localized to a 180-base pair fragment that st
imulates transcription from the aps(a) promoter 4-8-fold in HepG2 cell
s. Mutations within an Spl site or either of two elements composed of
direct repeats of the nuclear hormone receptor half-site AGGTCA in thi
s sequence completely abolished enhancer function. Both nuclear hormon
e receptor elements were shown to bind peroxisome proliferator-activat
ed receptors and other members of the nuclear receptor family, suggest
ing that this enhancer may mediate drug and hormone responsiveness.